PharmaCyte Biotech, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • PharmaCyte Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending July 31, 2024 was $23.4M.
  • PharmaCyte Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending July 31, 2024 was $26.9M.
  • PharmaCyte Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $334K.
  • PharmaCyte Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$4.32M, a 1.81% decline from 2021.
  • PharmaCyte Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$4.24M, a 19.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $26.9M $23.4M +$26.6M May 1, 2024 Jul 31, 2024 10-Q 2024-09-17
Q1 2024 $334K $1.35M +$1.47M Feb 1, 2024 Apr 30, 2024 10-K 2024-08-13
Q4 2023 -$1.14M -$620K +$145K +18.9% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 -$1.28M $2.79M +$4.67M Aug 1, 2023 Oct 31, 2023 10-Q 2024-03-18
Q2 2023 -$5.95M -$3.18M -$1.64M -106% May 1, 2023 Jul 31, 2023 10-Q 2024-09-17
Q1 2023 -$4.32M -$126K +$1.3M +91.1% Feb 1, 2023 Apr 30, 2023 10-K 2024-08-13
Q4 2022 -$5.61M -$764K +$47.2K +5.81% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 -$5.66M -$1.88M -$901K -91.9% Aug 1, 2022 Oct 31, 2022 10-Q 2024-03-18
Q2 2022 -$4.76M -$1.55M -$520K -50.7% May 1, 2022 Jul 31, 2022 10-Q 2024-03-18
Q1 2022 -$4.24M -$1.42M -$463K -48.2% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-31
Q4 2021 -$3.78M -$811K -$54.2K -7.16% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 -$3.72M -$980K -$29.6K -3.11% Aug 1, 2021 Oct 31, 2021 10-Q 2023-03-16
Q2 2021 -$3.69M -$1.03M -$141K -16% May 1, 2021 Jul 31, 2021 10-Q 2023-03-16
Q1 2021 -$3.55M -$960K -$210K -27.9% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-28
Q4 2020 -$3.34M -$757K +$118K +13.5% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 -$3.46M -$950K +$117K +11% Aug 1, 2020 Oct 31, 2020 10-Q 2022-03-15
Q2 2020 -$3.58M -$884K +$250K +22.1% May 1, 2020 Jul 31, 2020 10-Q 2022-03-15
Q1 2020 -$3.83M -$750K +$389K +34.1% Feb 1, 2020 Apr 30, 2020 10-K 2021-08-10
Q4 2019 -$4.22M -$875K -$199K -29.4% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-12
Q3 2019 -$4.02M -$1.07M -$30.5K -2.95% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 -$3.99M -$1.13M +$81.3K +6.69% May 1, 2019 Jul 31, 2019 10-Q 2020-09-11
Q1 2019 -$4.07M -$1.14M +$157K +12.1% Feb 1, 2019 Apr 30, 2019 10-K 2020-08-13
Q4 2018 -$4.22M -$676K +$1.35M +66.7% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-13
Q3 2018 -$5.58M -$1.04M +$778K +42.9% Aug 1, 2018 Oct 31, 2018 10-Q 2020-03-13
Q2 2018 -$6.36M -$1.22M +$473K +28% May 1, 2018 Jul 31, 2018 10-Q 2020-03-13
Q1 2018 -$6.83M -$1.3M -$140K -12.2% Feb 1, 2018 Apr 30, 2018 10-K 2019-08-13
Q4 2017 -$6.69M -$2.03M -$749K -58.4% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-14
Q3 2017 -$5.94M -$1.81M -$840K -86.2% Aug 1, 2017 Oct 31, 2017 10-Q 2019-03-14
Q2 2017 -$5.1M -$1.69M -$656K -63.6% May 1, 2017 Jul 31, 2017 10-Q 2019-03-14
Q1 2017 -$4.44M -$1.16M -$33K -2.94% Feb 1, 2017 Apr 30, 2017 10-K 2017-07-27
Q4 2016 -$4.41M -$1.28M +$509K +28.4% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 -$4.92M -$975K +$661K +40.4% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-14
Q2 2016 -$5.58M -$1.03M +$483K +31.9% May 1, 2016 Jul 31, 2016 10-Q 2017-09-13
Q1 2016 -$6.06M -$1.12M +$2.9M +72.1% Feb 1, 2016 Apr 30, 2016 10-K 2017-07-27
Q4 2015 -$8.96M -$1.79M -$333K -22.8% Nov 1, 2015 Jan 31, 2016 10-K 2017-07-27
Q3 2015 -$8.63M -$1.64M +$1.23M +42.9% Aug 1, 2015 Oct 31, 2015 10-K 2017-07-27
Q2 2015 -$9.86M -$1.52M +$69.8K +4.4% May 1, 2015 Jul 31, 2015 10-K 2017-07-27
Q1 2015 -$9.93M -$4.02M +$12.5M +75.6% Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 -$22.4M -$1.46M -$999K -218% Nov 1, 2014 Jan 31, 2015 10-K 2016-07-29
Q3 2014 -$21.4M -$2.86M +$2.79M +49.4% Aug 1, 2014 Oct 31, 2014 10-K 2016-07-29
Q2 2014 -$24.2M -$1.58M +$3.08M +66% May 1, 2014 Jul 31, 2014 10-K 2016-07-29
Q1 2014 -$27.3M -$16.5M -$16.1M -4923% Feb 1, 2014 Apr 30, 2014 10-K/A 2016-01-19
Q4 2013 -$11.1M -$459K -$81.9K -21.7% Nov 1, 2013 Jan 31, 2014 10-K/A 2016-01-19
Q3 2013 -$11M -$5.66M -$5.28M -1378% Aug 1, 2013 Oct 31, 2013 10-K/A 2016-01-19
Q2 2013 -$5.75M -$4.67M -$4.16M -814% May 1, 2013 Jul 31, 2013 10-K/A 2016-01-19
Q1 2013 -$1.6M -$328K +$176K +35% Feb 1, 2013 Apr 30, 2013 10-K/A 2016-01-19
Q4 2012 -$1.77M -$377K -$105K -38.7% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$1.67M -$383K +$54.3K +12.4% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-16
Q2 2012 -$1.72M -$511K +$176K +25.6% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 -$1.9M -$504K +$589K +53.9% Feb 1, 2012 Apr 30, 2012 10-K 2013-07-29
Q4 2011 -$2.49M -$272K -$148K -119% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-26
Q3 2011 -$2.34M -$437K -$391K -854% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-26
Q2 2011 -$1.95M -$686K -$552K -411% May 1, 2011 Jul 31, 2011 10-Q 2012-09-19
Q1 2011 -$1.4M -$1.09M Feb 1, 2011 Apr 30, 2011 10-K 2012-08-14
Q4 2010 -$124K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
Q3 2010 -$45.8K Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
Q2 2010 -$134K May 1, 2010 Jul 31, 2010 10-Q/A 2011-09-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.